Attached files

EXHIBIT  32.1

                                 CERTIFICATION
                           Pursuant to 18 U.S.C. 1350
                (Section 906 of the Sarbanes-Oxley Act of 2002)

In connection with the Quarterly Report on Form 10-Q/A of Lightlake Therapeutics
Inc.  (the"Company")  for  the  year  ended  July  31,  2008,  as filed with the
Securities  and Exchange Commission on the date hereof (the "Report"), Dr. Roger
Crystal,  as  Chief Executive Officer of the Company, hereby certifies, pursuant
to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of
2002,  that:

     (1)  The  Report  fully  complies with the requirements of Section 13(a) or
          15(d)  of  the  Securities  Exchange  Act  of  1934;  and

     (2)  The  information  contained  in  the  Report  fairly  presents, in all
          material  respects,  the financial condition and results of operations
          of  the  Company.


Date:  3/15/10                          By:  /s/ Dr. Roger Crystal
                                             -----------------------------------
                                             Dr. Roger Crystal
                                             Chief Executive  Officer

This  certification  accompanies  each  Report  pursuant  to  ss.  906  of  the
Sarbanes-Oxley  Act  of 2002 and shalL not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of ss.18
of  the  Securities  Exchange  Act  of  1934,  as  amended.

A  signed  original  of  this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities  and  Exchange  Commission  or  its  staff  upon  request